protein kinase C epsilon inhibitors (Devgen)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameprotein kinase C epsilon inhibitors (Devgen)
Drug Alias NamePKC epsilon inhibitors (Devgen)KIN 1 modulators (Devgen)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinase C epsilon type inhibitors
TargetsProtein kinase C epsilon type
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDevgen NV
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDevgen NV
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A